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Update: Rural/Urban Disparities in Pneumococcal Vaccine Service Delivery
Among the Fee-for-Service Medicare Population, 2012-2015
Joseph Vanghelof, PharmD, MS; Aric Schadler, MS; Patricia R. Freeman, PhD; and Jeffery Talbert, PhD
Overview of Key Findings
▪

Between 2014 and 2015, the number of pneumococcal vaccine services delivered to fee-for-service
(FFS) Medicare beneficiaries increased by 380% as a result of uptake of PCV13 vaccine.
▪ Continued disparities in delivery of pneumococcal vaccine services to FFS Medicare beneficiaries in
rural and urban communities are noted, with a 63% higher vaccination rate observed in urban areas.
▪ The majority of pneumococcal vaccine services delivered to FFS Medicare beneficiaries were
provided by primary care providers, although pharmacy providers delivered close to one-fourth
(24.2%) of these services.
▪ Pharmacy providers in rural communities play an increasing role in pneumococcal vaccine service
delivery, providing one-third (33.5%) of vaccines in 2015.

Purpose
This Policy Brief is the second report from the Rural and Underserved Health Research Center assessing
rural/urban disparities in pneumococcal vaccine service delivery among the fee-for-service (FFS) Medicare
population. This report is an update of the initial report1 and was conducted to specifically assess uptake of the
13-valent pneumococcal conjugate vaccine (PCV13) following revised vaccination recommendations released
in 2014.

Introduction
Pneumococcal disease remains a significant public health concern in the U.S., especially for older adults where
mortality from invasive pneumococcal disease (IPD) ranges from 20% at age 65 to 40% at age 85.2 Current
recommendations from the Advisory Committee on Immunization Practices (ACIP), in place since September
2014, call for all persons age 65 and older to be vaccinated with a 2-dose vaccination series; 1 dose PCV13 at
age 65 and 1 dose 23-valent pneumococcal polysaccharide vaccine (PPSV23) at least 1 year later.3 The
previous recommendation for persons age 65 and older was to receive 1 dose of PPSV23, with PCV13 reserved
for those considered high risk. Recommendation for the 2-dose series was made following evidence showing
that up to 25% of IPD and 10% of community acquired pneumonia in older adults are caused by PCV13
vaccine serotypes.4 Despite these recommendations, vaccination rates remain low for either vaccine
individually (<50%) and for the complete 2-dose series (<20%), with racial and geographic disparities in
pneumococcal vaccination uptake noted.4
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Department of Health and Human Services (HHS) under cooperative agreement # U1CRH30041. The information, conclusions and opinions
expressed in this document are those of the authors and no endorsement by FORHP, HRSA, HHS, or the University of Kentucky is intended
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In a previous RUHRC report assessing pneumococcal vaccine service delivery in the FFS Medicare population,
we documented a significant disparity in pneumococcal vaccination rates between rural and urban areas across
the nation, with a 40% lower mean vaccination rate observed in rural communities in 2014.1 Overall,
pneumococcal vaccination service rates were low and varied considerably by state. Although primary care
providers delivered a majority of pneumococcal vaccine services to adults age 65 and older in the Medicare
FFS population, a significantly greater proportion of pneumococcal vaccine services was delivered by
pharmacy providers in rural areas, and regression models indicated that pharmacy providers had a significant
impact on pneumococcal vaccine delivery in rural areas.
Our previous report evaluated overall pneumococcal vaccination service delivery in the year 2014, without
assessing the contribution of the individual pneumococcal vaccines (PCV13 and PPSV23). The objective of
this study was to evaluate trends in pneumococcal vaccination service delivery for the years 2012 through
2015, and to specifically assess uptake of the PCV13 in 2015, the first full year following the revised
vaccination recommendations in September 2014. A secondary objective was to determine the relative
contribution of community pharmacies as an alternate site vaccine service provider to PCV13 uptake in rural
communities.

Methods
Vaccination service data were obtained from the Medicare Physician and Other Supplier Public Use File, which
reports the services and number of FFS beneficiaries treated by physicians and other providers.5 Services were
restricted to the following: administration of any pneumococcal vaccine via Healthcare Common Procedure
Coding System (HCPCS) G0009, PCV13 administration via Current Procedural Terminology (CPT) 90670,
and PPSV23 administration via CPT 90732. Providers were classified as either: 1) primary care provider (e.g.,
nurses, physician assistants, and family practice physicians); 2) pharmacy provider; or 3) other providers (e.g.,
physician specialists). Provider county was estimated using provider zip code, then linked to Rural-Urban
Continuum Codes (RUCC) and the Medicare Geographic Variation State/County table Public Use File. RUCC
classifies counties on a scale of 1 to 9, with 1-3 designated as urban, and 4-9 as rural.6 The Medicare
Geographic Variation table reports for each county: the number of FFS enrollees; average age; average
Hierarchical Condition Category (HCC) score, a composite risk score reflective of chronic disease burden; and
percent male, white non-Hispanic, eligible for Medicaid, and using inpatient or outpatient services.7
Descriptive statistics on vaccine services by rural-urban designation, provider type, vaccine type, and year were
calculated. A logistic regression model of the estimated rate of pneumococcal vaccination in 2015 was created
using the parameters from the Medicare Geographic Variation table, rural-urban designation, the percent of
vaccines provided by pharmacists, and the interaction of rural-urban designation with percent of vaccines
provided by pharmacists.

Findings
The number and rate of pneumococcal vaccination services delivered by FFS Medicare providers to eligible
beneficiaries increased annually between 2012 and 2015. In 2015, pneumococcal vaccine services were
delivered by providers to approximately 5,353,000 FFS beneficiaries representing 16% of the FFS population
nationwide, a 380% increase over that reported in 2014.1 Consistent with our previous findings, continued
disparities in pneumococcal vaccine service delivery are noted between rural and urban communities with an
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estimated 10.7% of FFS beneficiaries receiving
pneumococcal vaccination services in rural communities
compared to 17.4% in urban communities, signifying a
63% higher vaccination rate in urban communities.

Table 1. Total Number of PPSV23 and PCV13
Vaccination Services, in Thousands, 2012-2015
Year

PPSV23

PCV13

2012

1,067 (97.7%)

25 (2.3%)

Prior to 2015, the vast majority of pneumococcal vaccine
2013
1,077 (92.3%)
90 (7.7%)
services provided were for PPSV23, as expected based on
2014
1,025 (66.9%)
507 (33.1%)
ACIP recommendations for adults 65 and older (Table 1).
In 2015, following the revised recommendations for the 22015
445 (8.4%)
4,852 (91.6%)
dose vaccination series with PCV13 followed by PPSV23
at least 1 year later, PCV13 comprised over 90% of all pneumococcal vaccine services. The increase in the rate
of pneumococcal vaccination service delivery noted in 2015 was driven by uptake in the rate of PCV13
vaccination services.
Table 2. Number of Pneumococcal Vaccination Services by
Provider Type and Rural-Urban Designation, in Thousands, 2015
Provider
Type

Rural
Vaccination
Services

Urban
Vaccination
Services

Combined
Vaccination Services

Pharmacy

247

(33.5%)

1,049

(22.7%)

1,296

(24.2%)

Primary Care

465

(63.1%)

3,398

(73.6%)

3,863

(72.2%)

Other

25

(3.4%)

168

(3.6%)

193

(3.6%)

Total

737

5,353

(100%)

4,615

As shown in Table 2, in 2015, primary
care providers delivered the majority
(72.2%) of pneumococcal vaccination
services to FFS Medicare beneficiaries
while pharmacy providers accounted
for one-fourth. In rural communities,
pharmacy providers delivered one-third
of pneumococcal vaccine services,
suggesting the important role of rural
pharmacies in vaccine access.

To further assess the contribution of rural pharmacies to vaccine access, we assessed trends in pneumococcal
vaccine delivery by provider type in rural and urban communities from 2012 to 2015 (Figure 1). The
proportion of pneumococcal vaccines provided by pharmacists in rural areas increased from 19.9% in 2012 to
33.5% in 2015 but has only modestly increased in urban areas (20.4% to 22.6%).
Figure 1. Percent of Pneumococcal Vaccination Services Delivered by
Provider Type and Rural-Urban Designation, 2012 to 2015
100
80
60

Other
Primary Care

40

Pharmacy
20
0
2012

2013

2014

Rural
Rural & Underserved Health Research Center

2015

2012

2013

2014

2015

Urban
Page 3

Disparities in Pneumococcal Vaccine Delivery

Policy Brief

In 2015, pneumococcal vaccination service rates among FFS beneficiaries varied by state and ranged from 8%
in Maine to 26% in Colorado (Figure 2, right panel). In comparison, the range during 2014 was 1% to 6%
(Figure 2, left panel). Although overall pneumococcal vaccination rates in the FFS Medicare population have
increased, a widening gap between highest and lowest vaccination rates in states (5% in 2014 vs 18% in 2015)
is noted. Further county-level pneumococcal vaccinating service visualizations are available at our website:
https://ruhrc.uky.edu/infographics/.

Figure 2. Rate of Pneumococcal Vaccine Service Delivery per Eligible Population, 2014-2015

2014 (scale:1.1%-6.3%)

2015 (scale:7.7%-25.7%)

Logistic regression indicates that increasing age of beneficiaries, greater proportion of female beneficiaries, and
greater proportion of white non-Hispanic beneficiaries were positively associated with uptake of pneumococcal
vaccine services, while rurality, greater use of outpatient services, and lower overall health status were
negatively associated with uptake of pneumococcal vaccine services. The interaction between rurality and
percent of vaccines provided by pharmacists was significant (P < .0001), and when interpreted with the finding
from Figure 1 that pharmacists provide a greater proportion of vaccines in rural versus urban areas, suggests
that community pharmacies play an important role in access to pneumococcal vaccinations in rural areas.

Conclusion/Discussion
We assessed pneumococcal vaccination service records for FFS beneficiaries from 2012, the first year during
which PCV13 was recommended for high-risk adults age 20 and older, through 2015, the first full year during
which PCV13 was recommended for all adults 65 and older. Among FFS beneficiaries from 2012 to 2015, the
number of pneumococcal vaccination services increased greatly, and providers shifted from principally
administering PPSV23 to PCV13. We estimate that in 2015, 16% of FFS beneficiaries received pneumococcal
vaccination, with 92% administered PCV13. During years prior to 2015, there were lower rates of
pneumococcal vaccination and much less frequent use of PCV13. Therefore, as of 2015, the majority of FFS
beneficiaries remained to be vaccinated with PCV13 and it is likely pneumococcal vaccination services after
2015 will remain elevated. Overall, rural areas experienced a lower rate of pneumococcal vaccination, and
primary care providers were the most frequent contributors to pneumococcal vaccination. As primary care
shortages in rural areas continue to grow, however, pharmacists appear to play an increasing role in providing
vaccines in rural areas and have consistent importance in urban areas.
In summary, following recommendations for administration of PCV13 to all adults 65 and older in September
2014, pneumococcal vaccination rates increased almost 4-fold between 2014 and 2015. Continued disparities in
Rural & Underserved Health Research Center
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pneumococcal vaccination rates between rural and urban areas are noted, with community pharmacies serving
as an important access point for pneumococcal vaccine services in rural communities. Given that the population
of rural areas has a greater proportion of older adults than urban areas,8 continued support of rural service
providers, including both primary care providers and pharmacists, is needed to ensure older adults have access
to recommended vaccines.
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